Angielski
This Reprint, "Molecular Advances in Dry Eye Syndrome", presents a collection of recent studies that explore the biological, biochemical, and immunological mechanisms underlying dry eye disease. This Reprint highlights the latest progress in lipidomics, extracellular vesicle biology, neurosensory regulation, and immune dysregulation, as well as emerging pharmacological and biological therapies. Together, these contributions provide an integrated molecular perspective on disease pathophysiology, identify novel biomarkers and therapeutic targets, and outline strategies for more personalized diagnostic and treatment approaches. The Reprint offers researchers and clinicians an updated and comprehensive overview of current scientific advances shaping the future of dry eye disease management.
